Live feed16:10:12·1104dSECFilingvia QuantisnowNeuBase Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.NBSE· NeuBase Therapeutics Inc.Health CareOriginal source
